Skip to content

Management of Paroxystic Atrial Fibrillation in French Intensive Care Units

Management of Paroxystic Atrial Fibrillation in French Intensive Care Units

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03977883
Acronym
PAF-ICU
Enrollment
742
Registered
2019-06-06
Start date
2019-05-13
Completion date
2020-08-27
Last updated
2021-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ICU Patients, New Onset Atrial Fibrillation

Keywords

New onset atrial fibrillation, Paroxystic atrial fibrillation, ICU patients, Rate control, Rhythm control

Brief summary

The primary purpose of the study is to evaluate treatment of new onset atrial fibrillation in french ICU.

Detailed description

Atrial fibrillation (AF) is a common arrhythmia in the ICU and is associated with significant morbidity. However, curative treatment remains unclearly established. In fact, there are no specific recommendations for new onset atrial fibrillation in ICU and only few studies have assessed this topic. The PAF-ICU trial is an observational, prospective, multicenter, transversal trial. The main objective is to evaluate the management of paroxytic atrial fibrillation that occur in ICU. The investigators want to document 2500 episodes of paroxystic atrial fibrillation in 50 ICU centers. In each center, the episodes are included consecutively until the required 50 episodes are obtained for each center. A patient can present several episodes and each episode can be included in the study. A new episode is considered as such if it occurs more than one hour after the previous episode. The follow-up period for each patient corresponds to the ICU stay.

Interventions

None listed

Sponsors

French Society of Anesthesia and Intensive Care Medecine
CollaboratorUNKNOWN
University Hospital, Clermont-Ferrand
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \> 18 years * Patient hospitalized in ICU * New onset atrial fibrillation

Exclusion criteria

* Age \< 18 years * Parturient or breast-feeding woman * Persistent or permanent atrial fibrillation * Patients after cardiovascular or thoracic surgery * Patients with therapeutic limitations

Design outcomes

Primary

MeasureTime frameDescription
Management of Atrial FibrillationICU stay (until 28 days)All types of therapeutics used to manage atrial fibrillation are collected

Secondary

MeasureTime frameDescription
Blood pressureBefore, 5 minutes, 30 minutes, 1 hour, and 24 hours after atrial fibrillationBlood pressure. Unit : Millimeters of mercury
Heart rateBefore, 5 minutes, 30 minutes, 1 hour, and 24 hours after atrial fibrillationHeart rate. Unit : beats per minute
Cardiac outputBefore, 5 minutes, 30 minutes, 1 hour, and 24 hours after atrial fibrillationProduct of the heart rate (HR) and the stroke volume (SV), which is the volume of blood pumped from the ventricle per beat. Unit : L/min.
Cardiac rhythm statusBefore, 5 minutes, 30 minutes, 1 hour, and 24 hours after atrial fibrillationType of rhythm : Normal (sinus rhythm), Atrial Fibrillation, Other disturbance
VasopressorsBefore, 5 minutes, 30 minutes, 1 hour, and 24 hours after atrial fibrillationType of vasopressors used
StrokeICU Stay up to 28 daysOccurrence of stroke during ICU stay
ScvO2Before, 5 minutes, 30 minutes, 1 hour, and 24 hours after atrial fibrillationVenous saturation. Unit : percentage

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026